FDA Orange Book
Generic for Glumetza
Glumetza contains metformin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Glumetza is metformin. 29 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB1, AB2, AB3.
Run it in Rivvi
Map Glumetza and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Glumetza products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, extended release, oral | 1GM | Discontinued | None | 16 | AB2, AB3 |
| tablet, extended release, oral | 500MG | Discontinued | None | 35 | AB1, AB2, AB3 |
NDA 021748, held by SANTARUS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic metformin
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA INC | 076269 | AB1 (A-rated, therapeutically equivalent) | June 18, 2004 | 500MG |
| SANDOZ INC | 076873 | AB1 (A-rated, therapeutically equivalent) | December 14, 2004 | 500MG |
| ZYDUS LIFESCIENCES LTD | 077060 | AB1 (A-rated, therapeutically equivalent) | April 20, 2005 | 500MG |
| NOSTRUM PHARMACEUTICALS LLC | 076756 | AB1 (A-rated, therapeutically equivalent) | July 26, 2006 | 500MG |
| CSPC OUYI PHARMACEUTICAL CO LTD | 078321 | AB1 (A-rated, therapeutically equivalent) | April 17, 2008 | 500MG |
| LUPIN LTD | 090692 | AB2 (A-rated, therapeutically equivalent) | June 29, 2011 | 1GM, 500MG |
| ADAPTIS PHARMA PRIVATE LTD | 201991 | AB1 (A-rated, therapeutically equivalent) | January 18, 2012 | 500MG |
| AUROBINDO PHARMA LTD | 079118 | AB1 (A-rated, therapeutically equivalent) | July 20, 2012 | 500MG |
| MYLAN PHARMACEUTICALS INC | 200690 | AB2 (A-rated, therapeutically equivalent) | August 1, 2012 | 1GM, 500MG |
| LUPIN LTD | 091664 | AB3 (A-rated, therapeutically equivalent) | July 19, 2013 | 1GM, 500MG |
| PHARMAZONE | 090295 | AB1 (A-rated, therapeutically equivalent) | April 29, 2016 | 500MG |
| ACTAVIS LABORATORIES FL INC | 203755 | AB3 (A-rated, therapeutically equivalent) | August 1, 2016 | 1GM, 500MG |
| MACLEODS PHARMACEUTICALS LTD | 206955 | AB1 (A-rated, therapeutically equivalent) | December 7, 2016 | 500MG |
| REGCON HOLDINGS LLC | 207427 | AB1 (A-rated, therapeutically equivalent) | December 13, 2016 | 500MG |
| PLATINUM PHARMACEUTICALS | 202306 | AB1 (A-rated, therapeutically equivalent) | February 23, 2017 | 500MG |
| MPP PHARMA LLC | 203832 | AB2 (A-rated, therapeutically equivalent) | December 26, 2017 | 1GM, 500MG |
| GRANULES INDIA LTD | 209313 | AB1 (A-rated, therapeutically equivalent) | March 16, 2018 | 500MG |
| ALIGNSCIENCE PHARMA INC | 209303 | AB1 (A-rated, therapeutically equivalent) | March 19, 2018 | 500MG |
| PRINSTON PHARMACEUTICAL INC | 208880 | AB1 (A-rated, therapeutically equivalent) | September 10, 2018 | 500MG |
| YICHANG HUMANWELL PHARMACEUTICAL CO LTD | 211052 | AB1 (A-rated, therapeutically equivalent) | September 24, 2018 | 500MG |
| ALKEM LABORATORIES LTD | 206145 | AB1 (A-rated, therapeutically equivalent) | October 22, 2018 | 500MG |
| NOVAST LABORATORIES LTD | 209674 | AB2 (A-rated, therapeutically equivalent) | November 2, 2018 | 1GM, 500MG |
| QINGDAO BAHEAL PHARMACEUTICAL CO LTD | 209993 | AB2 (A-rated, therapeutically equivalent) | December 27, 2018 | 1GM, 500MG |
| GLENMARK PHARMACEUTICALS LTD | 212969 | AB3 (A-rated, therapeutically equivalent) | November 25, 2019 | 1GM, 500MG |
| AJANTA PHARMA LTD | 213651 | AB2 (A-rated, therapeutically equivalent) | April 9, 2020 | 1GM, 500MG |
| GRANULES INDIA LTD | 213344 | AB3 (A-rated, therapeutically equivalent) | January 12, 2021 | 1GM |
| AJANTA PHARMA LTD | 213962 | AB3 (A-rated, therapeutically equivalent) | March 9, 2021 | 1GM |
| SCIEGEN PHARMACEUTICALS INC | 213334 | AB3 (A-rated, therapeutically equivalent) | April 16, 2021 | 1GM |
| SCIEGEN PHARMACEUTICALS INC | 214629 | AB2 (A-rated, therapeutically equivalent) | February 22, 2022 | 1GM |
| PRINSTON PHARMACEUTICAL INC | 212681 | AB3 (A-rated, therapeutically equivalent) | June 9, 2022 | 1GM |
| MICRO LABS LTD | 212448 | AB3 (A-rated, therapeutically equivalent) | January 10, 2023 | 1GM |
| AUROBINDO PHARMA LTD | 209694 | AB2 (A-rated, therapeutically equivalent) | October 18, 2024 | 1GM |
Glumetza NDC codes
Questions
Is there a generic for Glumetza?
Yes. The generic name for Glumetza is metformin. 29 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB1, AB2, AB3.
What is the generic name for Glumetza?
The active ingredient in Glumetza is metformin, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Glumetza and Metformin
- What is Metformin used for?FDA label uses
- Is Metformin a controlled substance?Federal schedule
- Generic for RiometFDA Orange Book
- Generic for FortametFDA Orange Book
- Generic for Glucophage XRFDA Orange Book
- Generic for GlucophageFDA Orange Book
- Biguanides listFDA drug class
- NDC 68012-002Glumetza NDC record
- NDC 68012-003Glumetza NDC record
- NDC 68012-004Glumetza NDC record